Cardiovascular pleiotropic actions of DPP-4 inhibitors: A step at the cutting edge in understanding their additional therapeutic potentials

Cellular Signalling

Volumn 25, Issue 9, 2013, Pages 1799-1803

  Balakumar, Pitchai ^a   Dhanaraj, Sokkalingam A ^a  

^a AIMST UNIVERSITY   (Malaysia)

Author keywords

Cardiovascular protection; Diabetes mellitus; DPP 4 inhibition; Gliptins

Indexed keywords

ALOGLIPTIN; DIPEPTIDYL PEPTIDASE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; INCRETIN; LINAGLIPTIN; SAXAGLIPTIN; SERINE PROTEINASE; SITAGLIPTIN; VILDAGLIPTIN;

ANTIDIABETIC ACTIVITY; BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DEGRADATION; DIABETIC PATIENT; DIET; DISEASE PREDISPOSITION; DRUG APPROVAL; DRUG MECHANISM; DRUG USE; EXERCISE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HORMONE RELEASE; HUMAN; INSULIN RELEASE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMALL INTESTINE; VASCULARIZATION;

ANIMALS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HUMANS; HYPOGLYCEMIC AGENTS;

EID: 84879258494     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2013.05.009     Document Type: Review

References (62)

1. 2013, http://www.idf.org/diabetesatlas/5e/the-global-burden. Accessed 21 February 2013. Fifth ed.
2. FDA Press News (Accessed 16 February 2013). http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm336942.htm.
3. Shetty P. Nature 2012, 485(7398):S14-S16.
4. Letchuman G.R., Wan Nazaimoon W.M., Wan Mohamad W.B., Chandran L.R., Tee G.H., Jamaiyah H., Isa M.R., Zanariah H., Fatanah I., Ahmad Faudzi Y. The Medical Journal of Malaysia 2010, 65:180-186.
5. Mooradian A.D. Archives of Internal Medicine 2003, 163:33-40.
6. Mikhail N. Expert Opinion on Investigational Drugs 2008, 17:845-853.
7. Balakumar P., Sharma N., Krishan P., Mahadevan N. International Journal of Recent Advances in Pharmaceutical Research 2011, 3:11-14.
8. Balakumar P. RGUHS - Journal of Pharmaceutical Sciences 2013, 3:1-5.
9. Pattzi H.M., Pitale S., Alpizar M., Bennett C., O'Farrell A.M., Li J., Cherrington J.M., Guler H.P. Diabetes, Obesity & Metabolism 2010, 12:348-355.
10. Yang S.J., Min K.W., Gupta S.K., Park J.Y., Shivane V.K., Pitale S.U., Agarwal P.K., Sosale A., Gandhi P., Dharmalingam M., Mohan V., Mahesh U., Kim D.M., Kim Y.S., Kim J.A., Kim P.K., Baik S.H. Diabetes, Obesity & Metabolism 2013, 15:410-416.
11. Rhee E.J., Lee W.Y., Min K.W., Shivane V.K., Sosale A.R., Jang H.C., Chung C.H., Nam-Goong I.S., Kim J.A., Kim S.W. Diabetes, Obesity & Metabolism 2013, 15:523-530.
12. Monami M., Lamanna C., Desideri C.M., Mannucci E. Advances in Therapy 2012, 29:14-25.
13. Thornberry N.A., Gallwitz B. Best Practice & Research. Clinical Endocrinology & Metabolism 2009, 23:479-486.
14. Balakumar P., Kaur T., Singh M. Toxicology 2008, 245:49-64.
15. Balakumar P., Kathuria S., Taneja G., Kalra S., Mahadevan N. Journal of Molecular and Cellular Cardiology 2012, 52:83-92.
16. Balakumar P., Kathuria S. British Journal of Pharmacology 2012, 166:1981-1992.
17. Kathuria S., Mahadevan N., Balakumar P. Molecular and Cellular Biochemistry 2013, 374:61-72.
18. Taneja G., Mahadevan N., Balakumar P. Cardiovascular Toxicology 2013, 10.1007/s12012-012-9190-y.
19. Mason R.P., Jacob R.F., Kubant R., Walter M.F., Bellamine A., Jacoby A., Mizuno Y., Malinski T. Journal of Atherosclerosis and Thrombosis 2011, 18:774-783.
20. Khan S., Khan S., Imran M., Pillai K.K., Akhtar M., Najmi A.K. Expert Opinion on Therapeutic Targets 2013, 17:627-639.
21. Ding L., Zhang J. Acta Pharmacologica Sinica 2012, 33:75-81.
22. Liu L., Liu J., Wong W.T., Tian X.Y., Lau C.W., Wang Y.X., Xu G., Pu Y., Zhu Z., Xu A., Lam K.S., Chen Z.Y., Ng C.F., Yao X., Huang Y. Hypertension 2012, 60:833-841.
23. Giannocco G., Oliveira K.C., Crajoinas R.O., Venturini G., Salles T.A., Fonseca-Alaniz M.H., Maciel R.M., Girardi A.C. European Journal of Pharmacology 2013, 698:74-86.
24. Pacheco B.P., Crajoinas R.O., Couto G.K., Davel A.P., Lessa L.M., Rossoni L.V., Girardi A.C. Journal of Hypertension 2011, 29:520-528.
25. Kubota Y., Miyamoto M., Takagi G., Ikeda T., Kirinoki-Ichikawa S., Tanaka K., Mizuno K. Journal of Korean Medical Science 2012, 27:1364-1370.
26. Satoh-Asahara N., Sasaki Y., Wada H., Tochiya M., Iguchi A., Nakagawachi R., Odori S., Kono S., Hasegawa K., Shimatsu A. Metabolism 2013, 62:347-351.
27. Barbieri M., Rizzo M.R., Marfella R., Boccardi V., Esposito A., Pansini A., Paolisso G. Atherosclerosis 2013, 227:349-354.
28. Matsubara J., Sugiyama S., Akiyama E., Iwashita S., Kurokawa H., Ohba K., Maeda H., Fujisue K., Yamamoto E., Kaikita K., Hokimoto S., Jinnouchi H., Ogawa H. Circulation Journal 2013, 77:1337-1344.
29. Ye Y., Keyes K.T., Zhang C., Perez-Polo J.R., Lin Y., Birnbaum Y. American Journal of Physiology. Heart and Circulatory Physiology 2010, 298:H1454-H1465.
30. Lenski M., Kazakov A., Marx N., Böhm M., Laufs U. Journal of Molecular and Cellular Cardiology 2011, 51:906-918.
31. Connelly K., Zhang Y., Advani A., Advani S., Thai K., Yuen D., Gilbert R. Cardiovascular Therapeutics 2013, (in press). 10.1111/1755-5922.12005.
32. Gomez N., Touihri K., Matheeussen V., Mendes Da Costa A., Mahmoudabady M., Mathieu M., Baerts L., Peace A., Lybaert P., Scharpé S., De Meester I., Bartunek J., Vanderheyden M., Mc Entee K. European Journal of Heart Failure 2012, 14:14-21.
33. Engel S.S., Golm G.T., Shapiro D., Davies M.J., Kaufman K.D., Goldstein B.J. Cardiovascular Diabetology 2013, 12:3.
34. Read P.A., Khan F.Z., Heck P.M., Hoole S.P., Dutka D.P. Circulation. Cardiovascular Imaging 2010, 3:195-201.
35. Theiss H.D., Brenner C., Engelmann M.G., Zaruba M.M., Huber B., Henschel V., Mansmann U., Wintersperger B., Reiser M., Steinbeck G., Franz W.M. International Journal of Cardiology 2010, 145:282-284.
36. Matsui T., Nishino Y., Takeuchi M., Yamagishi S. Pharmacological Research 2011, 63:383-388.
37. van Poppel P.C., Netea M.G., Smits P., Tack C.J. Diabetes Care 2011, 34:2072-2077.
38. Matikainen N., Taskinen M.R. Diabetic Medicine 2013, 30:756-757.
39. He Y.L., Zhang Y., Serra D., Wang Y., Ligueros-Saylan M., Dole W.P. Current Medical Research and Opinion 2011, 27:1453-1463.
40. Apaijai N., Pintana H., Chattipakorn S.C., Chattipakorn N. Endocrinology 2012, 153:3878-3885.
41. Apaijai N., Pintana H., Chattipakorn S.C., Chattipakorn N. British Journal of Pharmacology 2013, (in press). 10.1111/bph.12176.
42. Yin M., Silljé H.H., Meissner M., van Gilst W.H., de Boer R.A. Cardiovascular Diabetology 2011, 10:85.
43. Frederich R., Alexander J.H., Fiedorek F.T., Donovan M., Berglind N., Harris S., Chen R., Wolf R., Mahaffey K.W. Postgraduate Medicine 2010, 122:16-27.
44. Mason R.P., Jacob R.F., Kubant R., Ciszewski A., Corbalan J.J., Malinski T. Journal of Cardiovascular Pharmacology 2012, 60:467-473.
45. Cobble M.E., Frederich R. Cardiovascular Diabetology 2012, 11:6.
46. Scirica B.M., Bhatt D.L., Braunwald E., Steg P.G., Davidson J., Hirshberg B., Ohman P., Price D.L., Chen R., Udell J., Raz I. American Heart Journal 2011, 162:818-825.
47. Kröller-Schön S., Knorr M., Hausding M., Oelze M., Schuff A., Schell R., Sudowe S., Scholz A., Daub S., Karbach S., Kossmann S., Gori T., Wenzel P., Schulz E., Grabbe S., Klein T., Münzel T., Daiber A. Cardiovascular Research 2012, 96:140-149.
48. Chaykovska L., von Websky K., Rahnenführer J., Alter M., Heiden S., Fuchs H., Runge F., Klein T., Hocher B. PLoS One 2011, 6:e27861.
49. Ring A., Port A., Graefe-Mody E.U., Revollo I., Iovino M., Dugi K.A. British Journal of Clinical Pharmacology 2011, 72:39-50.
50. Balakumar P., Sharma N.K. Cellular Signalling 2012, 24:53-59.
51. Balakumar P., Babbar L. Cellular Signalling 2012, 24:589-595.
52. Babbar L., Mahadevan N., Balakumar P. Naunyn-Schmiedeberg's Archives of Pharmacology 2013, 386:319-329.
53. Sharma N.K., Mahadevan N., Balakumar P. Cardiovascular Toxicology 2013, 13:22-32.
54. Hocher B., Sharkovska Y., Mark M., Klein T., Pfab T. International Journal of Cardiology 2013, (in press). 10.1016/j.ijcard.2011.12.007.
55. Chinda K., Palee S., Surinkaew S., Phornphutkul M., Chattipakorn S., Chattipakorn N. International Journal of Cardiology 2013, (in press). 10.1016/j.ijcard.2012.01.011.
56. Johansen O.E., Neubacher D., von Eynatten M., Patel S., Woerle H.J. Cardiovascular Diabetology 2012, 11:3.
57. Shah Z., Pineda C., Kampfrath T., Maiseyeu A., Ying Z., Racoma I., Deiuliis J., Xu X., Sun Q., Moffatt-Bruce S., Villamena F., Rajagopalan S. Vascular Pharmacology 2011, 55:2-9.
58. Ta N.N., Schuyler C.A., Li Y., Lopes-Virella M.F., Huang Y. Journal of Cardiovascular Pharmacology 2011, 58:157-166.
59. Noda Y., Miyoshi T., Oe H., Ohno Y., Nakamura K., Toh N., Kohno K., Morita H., Kusano K., Ito H. Cardiovascular Diabetology 2013, 12:8.
60. White W.B., Bakris G.L., Bergenstal R.M., Cannon C.P., Cushman W.C., Fleck P., Heller S., Mehta C., Nissen S.E., Perez A., Wilson C., Zannad F. American Heart Journal 2011, 162:620-626.
61. Singh S., Chang H.Y., Richards T.M., Weiner J.P., Clark J.M., Segal J.B. JAMA Internal Medicine 2013, 1-6.
62. Drug Safety Communications (Accessed on 15 March, 2013). http://www.fda.gov/Drugs/DrugSafety/ucm343187.htm.